Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × Interleukin-2 × 1 year × Clear all

Sponsor

Conditions

Melanoma 18 Neoplasm Metastasis 8 Ovarian Neoplasms 7 Lymphoma, Non-Hodgkin 7 Colorectal Neoplasms 7 Leukemia, Myeloid, Acute 6 Carcinoma, Non-Small-Cell Lung 6 Skin Neoplasms 5 Uveal Melanoma 4 Squamous Cell Carcinoma of Head and Neck 4 Neoplasms 4 Lymphoma 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Triple Negative Breast Neoplasms 3 Stomach Neoplasms 3 Recurrence 3 Multiple Myeloma 3 Lymphoma, Follicular 3 Lung Neoplasms 3 Leukemia 3 Esophageal Neoplasms 3 Uterine Cervical Neoplasms 2 Sarcoma 2 Rectal Neoplasms 2 Pancreatic Neoplasms 2 Neuroblastoma 2 Myelodysplastic Syndromes 2 Mesothelioma, Malignant 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, B-Cell, Marginal Zone 2

Interventions

pembrolizumab 38 Gemcitabine 20 enfortumab vedotin 19 Cisplatin 17 Nivolumab 16 atezolizumab 14 Magnetic Resonance Spectroscopy 14 avelumab 13 Carboplatin 12 Specimen Handling 10 Docetaxel 10 sacituzumab govitecan 9 Paclitaxel 7 Ipilimumab 7 Fluorodeoxyglucose F18 5 pemigatinib 4 toripalimab 3 erdafitinib 3 durvalumab 3 cabozantinib 3 X-Rays 3 Taxes 3 Mitomycin 3 Immunoglobulin G 3 CTLA-4 Antigen 3 Biopsy 3 tislelizumab 2 lenvatinib 2 eribulin 2 dodecyl maltoside 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡